Submitted by CDC_DSMH_WG on
CDC's Consolidated Comment for USCDI v5
- Specimen collection date/time is created at the provider side when a specimen is collected for laboratory testing. EHRs capture it during test order creation and exchange it with the laboratory as part of the order message. A proper test interpretation can only be given for most test types with knowing the specimen collection date/time. Laboratories are required to receive this as per CLIA requirement §493.1291(c)(6). Additionally, Disease reporting to public health relies on data from the EHR for the identification of reportable events and to provide critical information used in confirming a diagnosis, understanding the severity, and classifying a case of disease that requires public health intervention for prevention, treatment, control, and outbreak identification and response. The specimen collection date is particularly important for public health in understanding when laboratory-confirmable evidence of a disease process was present in the patient. This data element can provide important time trends and surge capacity information during public health response.
- This may seem represented by the “Performance time” element applicable to a procedure. The specimen collection method is different from a procedure. It is currently not considered a procedure in EHR data collection methods, and considering so will be a major deviation from current practice. Specimen collection date/time is considered a test's “clinically relevant time” and not a procedure.
- NAACCR Comment: Agreed, important for cancer (and other public health) reporting.
- NACCHO Comment: Supports CDC's comment.







Submitted by CDC_DSMH_WG on
CDC's comment on behalf of CSTE for USCDI v5